Drug Type CAR-NK |
Synonyms- |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), Immunologic cytotoxicity |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | CN | 25 May 2022 | |
Chronic Lymphocytic Leukemia | Phase 1 | CN | 25 May 2022 | |
Non-Hodgkin Lymphoma | Phase 1 | CN | 25 May 2022 |